<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03588338</url>
  </required_header>
  <id_info>
    <org_study_id>2017/1081</org_study_id>
    <nct_id>NCT03588338</nct_id>
  </id_info>
  <brief_title>Paracetamol vs Metoclopramide on Postoperative Nausea and Vomiting</brief_title>
  <official_title>Comparison of Paracetamol and Metoclopramide on Postoperative Nausea and Vomiting Following Maxillofacial Surgery: a Prospective, Randomised, Double-blind Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aydin Adnan Menderes University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aydin Adnan Menderes University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The drugs with both high potency and low side effects are preferred in the prevention of
      postoperative nausea and vomiting (PONV) which is a common problem. This prospective
      randomized study aimed to compare the efficacy of paracetamol and metoclopramide on PONV in
      adults undergoing maxillofacial surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      One hundred-twenty patients are randomly divided into two groups; the paracetamol group who
      received the IV infusion of paracetamol (1.5 ml/kg); and the metoclopramide group who
      received the IV infusion of metoclopramide (0.2 mg/kg) in saline. The presence of vomiting
      and the actions indicative of nausea, such as repeated gagging or spitting, within 24h
      following general anesthesia are defined as PONV. All PONV episodes and postoperative pain
      scores are recorded during 24h postoperatively. The postoperative 0-4h and 4-24h are defined
      as early and late postoperative period, respectively. Intravenous 4 mg ondansetron as rescue
      antiemetic drug is administered in case of two or more vomiting episodes.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date type="Anticipated">July 20, 2018</start_date>
  <completion_date type="Anticipated">August 21, 2018</completion_date>
  <primary_completion_date type="Anticipated">August 20, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Preventing of postoperative nausea and vomiting</measure>
    <time_frame>First 24 hours postoperatively</time_frame>
    <description>Preventing of postoperative nausea and vomiting in postoperative care unit</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Postoperative Nausea and Vomiting</condition>
  <arm_group>
    <arm_group_label>Perfalgan</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1.5 mg/kg intravenous, intraoperative (20 min before end of the surgery)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Metoclopramide</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.2 mg/kg intravenous, intraoperative (20 min before end of the surgery)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Perfalgan</intervention_name>
    <description>For postoperative pain</description>
    <arm_group_label>Metoclopramide</arm_group_label>
    <arm_group_label>Perfalgan</arm_group_label>
    <other_name>Paracetamol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metoclopramide</intervention_name>
    <description>For postoperative nausea and vomiting</description>
    <arm_group_label>Metoclopramide</arm_group_label>
    <arm_group_label>Perfalgan</arm_group_label>
    <other_name>Metocloptamide hydrochloride</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA (the classification of the American Society of Anesthesiologists) physical status
             I-II

          -  Patients who scheduled for elective maxillofacial surgery under general anesthesia

        Exclusion Criteria:

          -  Patients with a history of allergy to any of the study medications (opioid, general
             anesthetic agents or paracetamol)

          -  History of opioid use, hepatic or renal disease, coronary, psychotic and neurologic
             diseases

          -  Use of antiemetic, antihistaminic, analgesic or corticosteroid 24 hours (h) prior to
             surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adnan Menderes University</last_name>
    <role>Study Director</role>
    <affiliation>Aydin Adnan Menderes University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ozlem Kocaturk</last_name>
    <phone>905367730400</phone>
    <email>ozlemoget2002@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tolga Kocaturk</last_name>
    <phone>905333444111</phone>
    <email>tolgakocaturk@gmail.com</email>
  </overall_contact_backup>
  <reference>
    <citation>Cok OY, Eker HE, Pelit A, Canturk S, Akin S, Aribogan A, Arslan G. The effect of paracetamol on postoperative nausea and vomiting during the first 24 h after strabismus surgery: a prospective, randomised, double-blind study. Eur J Anaesthesiol. 2011 Dec;28(12):836-41. doi: 10.1097/EJA.0b013e32834c580b.</citation>
    <PMID>21986980</PMID>
  </reference>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>July 5, 2018</study_first_submitted>
  <study_first_submitted_qc>July 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 17, 2018</study_first_posted>
  <last_update_submitted>July 5, 2018</last_update_submitted>
  <last_update_submitted_qc>July 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aydin Adnan Menderes University</investigator_affiliation>
    <investigator_full_name>Ozlem Kocaturk</investigator_full_name>
    <investigator_title>Faculty of Dentisty Oral and Maxillofacial Surgery</investigator_title>
  </responsible_party>
  <keyword>PONV</keyword>
  <keyword>Paracetamol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nausea</mesh_term>
    <mesh_term>Vomiting</mesh_term>
    <mesh_term>Postoperative Nausea and Vomiting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metoclopramide</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

